Daratumumab treatment in six highly sensitised solid organ transplant recipients: A case series and literature review
HLA · 2024
DOI: 10.1111/tan.15458 ↗Kurz gefasst
Fallbericht in der Zeitschrift HLA, 2024. Verfasst von Richard Lemal und 7 weiteren Autor:innen. Beteiligte Einrichtung: Service d'Histocompatibilité et Immunogénétique, Centre Hospitalo-Universitaire de Clermont-Ferrand, Clermont-Ferrand, France. Hauptthemen laut MEDLINE: Antibodies, Monoclonal, Kidney Transplantation. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 17 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
We report data on six kidney or heart recipients who were administered daratumumab to treat or prevent antibody‐mediated rejection (ABMR). To date, data are scarce concerning the use of daratumumab in solid organ transplantation and most reports show a decrease in donor‐specific antigen (DSA) levels and an improvement in ABMR using a multiple myeloma daratumumab administration scheme, that is, with sequential systematic administration. Here, we report on the efficacy of daratumumab 1/ in reducing the histological signs of ABMR, 2/ in reducing the ability of DSA to bind to donor cells in vitro through negativation of flow cytometry crossmatching, 3/ in preferentially being directed towards antibodies sharing epitopes, suggesting that daratumumab may specifically target activated plasma cells, 4/ and when administered as a single dose. This last point suggests, for the first time, that, as for rituximab in auto‐immune diseases, the scheme for daratumumab administration could be different for targeting DSA‐producing plasma cells than for tumour cells.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Service d'Histocompatibilité et Immunogénétique, Centre Hospitalo-Universitaire de Clermont-Ferrand, Clermont-Ferrand, France.
- EA 7453 CHELTER, Université Clermont Auvergne UCA, Clermont-Ferrand, France.
- Service de Néphrologie, Centre Hospitalo-Universitaire de Clermont-Ferrand, Clermont-Ferrand, France.
- Service de Cardiologie, Centre Hospitalo-Universitaire de Clermont-Ferrand, Clermont-Ferrand, France.
ORCID-Profile: Richard Lemal, Paul Rouzaire
Zitieren
APA
Lemal, R., Blandin, L., Uro-Coste, C., Philipponnet, C., Geoffroy, E., Heng, A. E., Garrouste, C., & Rouzaire, P. (2024). Daratumumab treatment in six highly sensitised solid organ transplant recipients: A case series and literature review. HLA. https://doi.org/10.1111/tan.15458
Vancouver
Lemal R, Blandin L, Uro-Coste C, Philipponnet C, Geoffroy E, Heng AE, et al. Daratumumab treatment in six highly sensitised solid organ transplant recipients: A case series and literature review. HLA. 2024. doi:10.1111/tan.15458
BibTeX
@article{Lemal2024,
author = {Lemal, Richard and Blandin, Lucie and Uro-Coste, Charlotte and Philipponnet, Carole and Geoffroy, Etienne and Heng, Anne-Elisabeth and Garrouste, Cyril and Rouzaire, Paul},
title = {Daratumumab treatment in six highly sensitised solid organ transplant recipients: A case series and literature review},
journal = {HLA},
year = {2024},
doi = {10.1111/tan.15458}
}
EUVIMED